![Niall M. B. Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Niall M. B. Martin
Fondateur chez Artios Pharma Ltd.
Provenance du réseau au premier degré de Niall M. B. Martin
Entité | Type d'entité | Industrie | |
---|---|---|---|
Artios Pharma Ltd.
![]() Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
KuDOS Pharmaceuticals Ltd.
![]() KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Niall M. B. Martin via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Secretary Corporate Officer/Principal | |
MedImmune Ltd.
![]() MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
SV Health Investors LLP
![]() SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biacore International AB
![]() Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Pharmaceuticals: Major | Director/Board Member | |
Gyros AB
![]() Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
POXEL | Pharmaceuticals: Major | Chairman Director/Board Member | |
MEDIVIR AB | Pharmaceuticals: Major | President | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Arrow Therapeutics Ltd.
![]() Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Oxagen Ltd.
![]() Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Euro-Diagnostica AB
![]() Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
GE Healthcare Ltd. (United Kingdom)
![]() GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Director/Board Member | |
The University of Reading | College/University | Undergraduate Degree | |
The University of Edinburgh | College/University | Doctorate Degree Doctorate Degree | |
University of Birmingham | College/University | Undergraduate Degree Graduate Degree | |
SOLEGREEN | Alternative Power Generation | Chairman | |
University College London | College/University | Doctorate Degree Doctorate Degree | |
BIOSEEK PLC | Miscellaneous Commercial Services | Director/Board Member | |
PricewaterhouseCoopers LLP (United Kingdom)
![]() PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Acacia Pharma Ltd.
![]() Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
AstraZeneca, Inc.
![]() AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ADC Products (UK) Ltd.
![]() ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director of Finance/CFO | |
Astra Pharmaceuticals Ltd.
![]() Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Astra Pharmaceuticals Ltd. manufactures & wholesales pharmaceutical products. The company was established in 1908 and is headquartered in London, GB | Pharmaceuticals: Major | Director/Board Member | |
Zenco (No. 8) Ltd.
![]() Zenco (No. 8) Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, Zenco (No. The company is based in Cambridge, UK and was founded in 1994. 8) Ltd. functions as an investment holding British company. | Financial Conglomerates | Director/Board Member | |
Astrazeneca Investments Ltd.
![]() Astrazeneca Investments Ltd. Financial ConglomeratesFinance Founded in 1992, Astrazeneca Investments Ltd. is a British dormant company that operates as a subsidiary of AstraZeneca PLC. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member | |
AstraZeneca US Investments Ltd.
![]() AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2002. | Financial Conglomerates | Director/Board Member | |
Astrazeneca Intermediate Holdings Ltd.
![]() Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member | |
Sky Medical Technology Ltd.
![]() Sky Medical Technology Ltd. Medical SpecialtiesHealth Technology Sky Medical Technology Ltd. provides medical products for cardio vascular diseases. It also provides electronic medical apparatus for the treatment of deep vein thrombosis and other circulatory disorders. The company was founded by Bernard Ross on March 22, 2006 and is headquartered in Daresbury, GB. | Medical Specialties | Director/Board Member | |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Founder | |
Scicona Ltd. | Chief Executive Officer | ||
Better All Round Ltd.
![]() Better All Round Ltd. Metal FabricationProducer Manufacturing Better All Round Ltd. develops and produces round kitchen towel rolls. The company was founded by Oday Abbosh and Colena Abbosh in 2012 and is headquartered in London, the United Kingdom. | Metal Fabrication | Chairman | |
SoniVie Ltd.
![]() SoniVie Ltd. Medical SpecialtiesHealth Technology SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel. | Medical Specialties | Director/Board Member Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Founder | |
Ipsen Bioinnovation Ltd.
![]() Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Cambridge Antibody Technology Group Ltd.
![]() Cambridge Antibody Technology Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, Cambridge Antibody Technology Group Ltd. is a holding company that oversees its subsidiaries' research, development, and exploitation of molecular engineering products. The company is based in Cambridge, UK and was founded in 1996. | Miscellaneous Commercial Services | Director/Board Member | |
AstraPharm
![]() AstraPharm Financial ConglomeratesFinance Founded in 1953, AstraPharm is a British dormant company that operates as a subsidiary of AstraZeneca PLC. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member | |
Upstream Bio, Inc.
![]() Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Astrazeneca Treasury Ltd.
![]() Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 35 |
Suède | 7 |
Etats-Unis | 6 |
Israël | 3 |
France | 2 |
Sectorielle
Health Technology | 29 |
Finance | 8 |
Commercial Services | 7 |
Consumer Services | 5 |
Utilities | 2 |
Opérationnelle
Director/Board Member | 224 |
Corporate Officer/Principal | 74 |
Chairman | 30 |
Chief Executive Officer | 25 |
Independent Dir/Board Member | 21 |
Relations les plus connectées
Insiders | |
---|---|
Raphaël Wisniewski | 45 |
Pierre Legault | 45 |
Barbara Dalton | 35 |
Chen-Ming Yu | 33 |
René Kuijten | 30 |
Michael Carter | 22 |
Ronald Eric Long | 19 |
Jonathan Leslie Tobin | 19 |
John Barrie Ward | 18 |
Zeev Zehavi | 18 |
Harry Finch | 15 |
Hamish Alan Cameron | 14 |
Adrian Charles Noel Kemp | 14 |
Nora Brennan | 13 |
Samantha Truex | 13 |
- Bourse
- Insiders
- Niall M. B. Martin
- Connexions Sociétés